Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| During our last call, I talked about our efforts to build a best-in-class commercial sales organization for profitable scalable growth inside and outside of PACE |
| It's a pretty unique scenario in that this client reached out to us last year with a pretty immediate need, we were able to onboard the customer within 60 days, which is a fantastic effort by our team here, and I think shows the scalability of our platform |
| Our revenue outperformance during the first quarter was driven primarily by two factors: higher than expected drug price inflation and an increase in pharmacy capacity due to staffing and automation, which will be important in meeting customer demand inherent in the growth we're experiencing |
| I think it's also a pretty positive sign that we're going to continue to see and even enhanced level of investment in the space, there's a lot of regulations right now that are proposed that support the model |
| These numbers represent one of the highest levels of organic growth we have generated as a public company |
| Medication revenue growth was primarily attributable to continued strong year-over-year PACE participant growth and higher revenue for PACE participants as seen in the operational metrics disclosed in our earnings press release |
| PACE is arguably the most successful example of value-based care and has demonstrated material reductions in hospitalization rates, ER utilization and healthcare costs compared to those individuals in long-term care settings |
| In many cases, over the years where clients have had an in-house pharmacy or part of a system that has an in-house pharmacy we have successfully been able to onboard those clients to our pharmacy services |
| I'm excited by our strong start to 2023 and the commitment from our 700-plus team members that are enabling Tabula Rasa to be successful |
| We've previously highlighted the growing presence of for-profit operators such as Welby Health, a longtime TRHC partner has a positive influence on the awareness and future growth of PACE |
| We're pretty excited about the growth rate within the PACE census, especially within our customer base today |
| In summary, we at Tabula Rasa believe there is a significant opportunity to not only drive continued organic revenue growth, but to make a profoundly positive impact on the lives of the individual eligible for this service, especially in rural areas of this country |
| Our backlog remains extremely healthy even with programs that arguably could have an in-house pharmacy |
| Our strong revenue growth combined with disciplined cost management has helped improve profitability |
| I'm proud of the work our sales and account management teams are doing |
| With Oak Street things remain very strong |
| We feel comfortable increasing our guidance due to our renewed focus and the consistent execution of our financial and strategic objectives, demonstrated over the last four quarters |
| We continue to see significant opportunities to drive the greater adoption of our solutions in PACE and our focus on these efforts has resulted in the average revenue per PACE participant increasing 22% versus a year ago to $523 |
| Another recent win from the quarter was a contract secured outside of PACE, with a Medicare-focused provider group serving rural America for our risk adjustment services, which represents one of our strongest growth areas inside and outside of PACE |
| And so I think that, that investment itself that we're seeing is going to yield some really positive things for Tabula Rasa, as we continue to support our customers so that they can scale and grow and support those patients even better |
| As we look ahead to the remainder of 2023, we are focused on building a strong foundation to drive future growth and profitability to create long-term value |
| In addition, we continue to see growth in our backlog during the quarter, which increased more than $6 million to $84 million on a sequential basis versus the end of 2022 |
| They've built great relationships with our existing clients and are ensuring prospects to understand the value of our solutions |
| Our adjusted EBITDA margin for the first quarter was 5.4%, which represented a nearly 380 basis point improvement versus a year ago and 40 basis points on a sequential basis versus the fourth quarter of 2022 |
| First quarter revenue of $88.3 million increased 32% versus the year ago quarter comprised of medication revenue growth of 35% and technology-enabled solutions revenue growth of 21% |
| The feedback has been very positive so far |
| I think there's a real appreciation for our ability to listen and take customer feedback in and include that as part of our road map going forward |
| Let's talk about the stuff completely, out of your control PACE census growth, it has been accelerating sequentially and it looks like it's doing pretty well quarter-to-date |
| Our PACE technology-enabled solutions census increased 8%, a year ago and our PACE average revenue per participant, per month for technology-enabled solutions increased 10% to $98 during the first quarter of 2023 |
| And so, it's been a really a good dialogue so far |
| Statement |
|---|
| And as I highlighted during our last earnings call, the second quarter adjusted EBITDA is negatively impacted by annual salary increases versus the first quarter of 2023 |
| And then it looks like if we calculate the non-PACE revenue, it looks like that declined about 12% sequentially |
| And that's likely to persist for the rest of the year |
| There were a number of things going on there that kind of held that down a bit |
| Our GAAP net loss for the quarter of $7.1 million, compared to a net loss of $20.4 million a year ago |
Please consider a small donation if you think this website provides you with relevant information